封面
市場調查報告書
商品編碼
1372866

拋棄式注射器市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測,按產品、按應用、最終用戶、地區和競爭細分

Disposable Syringes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Application, By End User, By Region and Competition

出版日期: | 出版商: TechSci Research | 英文 178 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年,全球拋棄式注射器市場估值達到142億美元,預計在預測期內將出現顯著成長,預計到2028年年複合成長率(CAGR)為6.10%。

拋棄式注射器由塑膠筒和針頭組成,有多種尺寸可供選擇。它們用於將液體、液體或化學物質安全地輸送到人體。拋棄式注射器的主要優點是拋棄式使用,無需維護和消毒。這不僅降低了營運成本,也最大限度地降低了滅菌後感染的風險。此外,拋棄式注射器配有針頭蓋,以保持無菌並防止意外接觸。

這些注射器的拋棄式特性有利於高效率的大規模生產,從而提高成本效益。不同類型的拋棄式注射器根據尺寸、尖端設計和針長度等因素進行分類,確保各種醫療應用的兼容性和適用性。

市場概況
預測期 2024-2028
2022 年市場規模 142億美元
2028 年市場規模 203.2億美元
2023-2028 年年複合成長率 6.10%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

主要市場促進因素

慢性疾病的盛行率不斷上升

慢性病病例的激增和針刺傷害的激增極大地促進了安全注射器市場的成長。根據美國疾病管制與預防中心(CDC)的報告,光是美國就有超過 300 萬名醫護人員因銳器和皮膚黏膜損傷而接觸血液和體液,每年導致 600 萬例針刺傷。這些針刺傷造成相當大的感染風險,愛滋病毒的傳播率低至 0.2% 至 0.5%,C型肝炎病毒的傳播率高達 3% 至 10%。就B型肝炎病毒而言,感染風險可高達 40%。這些感染的潛在致命性促使許多國家強制執行使用安全注射器的強制性規定,因為它們已被證明可以有效減少此類感染。因此,在這些關鍵因素以及加強病人安全和感染控制措施的迫切需求的推動下,對拋棄式注射器的需求持續成長。

老年人口的增加

成長的另一個重要推動因素是全球老年人口的不斷增加。 2 型糖尿病主要影響 45 歲及以上的族群,但其盛行率在年輕族群中逐漸增加。全球人口 78.75 億人中,65 歲以上人口約佔 9.6%。由於年事已高,老年人口也容易出現糖尿病以外的各種健康問題。這些情況需要醫療護理和藥液管理,從而推動了拋棄式注射器市場的成長。拋棄式注射器的技術進步增強了其吸引力,並成為市場成長的催化劑。除了治療各種疾病外,由於各種醫療狀況的流行,對採集血液樣本的需求不斷成長,進一步促進了全球拋棄式注射器市場的擴大。

全球針刺傷病例增加

針刺傷是由針尖造成的經皮刺傷,已成為醫療機構日益關注的問題。這些傷害可能發生在各種活動中,例如使用、處理、拆卸或處置針頭和注射器。由於其高發病率和相關的嚴重後果,醫療保健專業人員擴大使用具有安全機制的注射器來降低風險。對安全性的日益重視正在推動市場對拋棄式注射器的需求。

據代表歐洲醫療技術行業的組織 Eucomed 稱,該地區每年約有 100 萬起針刺傷事件。這令人震驚的統計數據凸顯了對預防措施和更安全的醫療設備的迫切需求。

全球拋棄式注射器市場也受到注射藥物市場持續成長和照護端管理需求不斷成長的影響。隨著越來越多的藥物透過注射給藥,對拋棄式注射器的需求持續成長。拋棄式注射器製造的技術進步在推動市場發展方面發揮著至關重要的作用。材料、設計和安全功能方面的創新正在增強拋棄式注射器的性能和可用性,使醫療保健專業人員更加可靠和方便。針刺傷的普遍存在以及對更安全醫療設備的需求推動了全球拋棄式注射器市場的發展。隨著人們對患者和醫護人員安全的日益關注,拋棄式注射器的需求預計在未來幾年將穩步成長。

面臨中風風險的患者數量不斷增加

面臨中風風險的患者數量不斷增加,引發了拋棄式注射器需求的大幅增加。這種日益成長的醫療保健問題是多種因素的直接後果,包括人口老化、生活方式的改變以及高血壓和糖尿病等慢性疾病的整體上升。隨著個體年齡的成長,他們對中風和相關併發症的易感性增加,需要頻繁的醫療干涉和注射。

拋棄式注射器已成為預防、診斷和治療中風相關問題不可或缺的工具。患有中風或有中風風險的患者通常需要定期進行血液檢查,以監測他們的膽固醇水平、凝血因子和血糖水平。這些注射器在精確抽取血液樣本、最大限度地降低污染風險以及確保醫療保健專業人員和患者的安全方面發揮關鍵作用。

透過拋棄式注射器施用抗凝血劑和溶栓劑等藥物在中風患者的治療中已變得司空見慣。這些注射器的拋棄式使用性質確保了準確的劑量,降低了感染風險,並消除了複雜的滅菌過程的需要,從而改善了患者的整體護理和安全。中風危險因子的日益普及增加了醫療保健領域對拋棄式注射器的需求。這些多功能儀器不僅有助於診斷和治療中風,而且有助於管理相關疾病,使其成為解決日益嚴重的中風流行病的現代醫療實踐的重要組成部分。隨著醫療保健提供者努力為不斷擴大的患者群體提供最高標準的護理,拋棄式注射器在中風管理中的作用將變得更加重要。

主要市場挑戰

拋棄式成本較高

在不已開發經濟體,甚至在發展中經濟體的某些地區,人們對醫療保健和安全問題的認知嚴重缺乏。這種認知的缺乏構成了嚴重的風險,因為人們仍然沒有意識到使用不可伸縮注射器的不安全做法可能導致多種傳染病和感染的迅速傳播。這種情況的後果可能是致命的,進一步加劇了解決這個問題的迫切性。

此外,在低度開發國家,基礎設施不足、資源有限、教育不足和技術不足等諸多挑戰導致人們對醫療中心的安全法和最佳實踐總體缺乏認知。這些因素,再加上與傳統注射器相比,可伸縮安全注射器的成本相對較高,成為市場成長和採用更安全的醫療保健實踐的主要限制因素。

應對這些多方面的挑戰需要各利益相關者的共同努力,包括政府、醫療保健組織和國際機構。透過優先考慮教育、改善基礎設施和促進獲得負擔得起的安全注射器,我們可以努力為所有人創造一個更安全的醫療環境,無論其地理位置或經濟狀況如何。

嚴格的政府法規

嚴格的政府法規對拋棄式注射器的需求產生了重大影響,為製造商和醫療保健提供者創造了一個充滿挑戰的環境。雖然實施法規的目的通常是確保安全和品質標準,但有時它們可能會無意中阻礙拋棄式注射器的可及性和可負擔性。嚴格法規影響需求的關鍵因素之一是對製造商實施嚴格的認證和批准流程。這些過程通常需要大量的時間和財力,導致市場進入延遲和生產成本增加。因此,這些額外的費用通常會轉嫁給醫療機構和消費者,從而使拋棄式注射器更加昂貴並減少其整體需求。

雖然嚴格的政府法規對於確保拋棄式注射器等醫療器材的安全性和有效性至關重要,但它們可能會因增加生產成本、限制創新和推高價格而無意中阻礙需求。平衡安全需求與負擔得起且易於使用的醫療保健工具的需求是一項微妙的任務,政策制定者必須仔細考慮,確保法規不會阻礙拋棄式注射器在醫療保健服務中發揮的重要作用。

主要市場趨勢

政府和組織越來越多的舉措

各國政府和國際衛生組織越來越重視免疫和疫苗接種運動。這種關注,特別是考慮到新冠肺炎 (COVID-19) 大流行等全球健康危機,導致疫苗生產和分發工作激增。拋棄式注射器在這方面至關重要,因為它們確保了疫苗的準確和安全管理。隨著各國政府致力於大規模疫苗接種活動並加強醫療基礎設施,對拋棄式注射器的需求必將飆升。旨在減少傳染病傳播的措施正在推動對安全注射實踐的需求。各國政府和組織擴大投資於減少傷害計劃,特別是在面臨靜脈注射毒品和愛滋病毒傳播相關挑戰的地區。這些計劃通常涉及分發無菌的拋棄式注射器,以盡量減少感染風險。因此,隨著這些減少傷害努力的擴大,對拋棄式注射器的需求預計將會增加。

此外,人們越來越認知到醫療保健衛生和感染控制的重要性,這進一步刺激了對拋棄式注射器的需求。世界各地的醫院、診所和醫療機構正在採取更嚴格的協議,以盡量減少醫療相關感染的風險。拋棄式注射器本質上是無菌且拋棄式的,是實現這些目標的關鍵組成部分。

自動注射器的使用不斷增加

由於自動注射器技術的快速進步,加上外科手術中對安全注射器的市場需求不斷增加,拋棄式注射器產業正在經歷逐步轉型。目前,已有20多家製藥公司生產了近80種自動注射器,大約有50種藥物正在開發為與自動注射器一起使用的組合產品。其中,拋棄式自動注射器佔62%的市場佔有率,而各種​​劑量的可重複使用自動注射器正在以驚人的速度開發中。設備製造業強調對使用者友善的小工具的需求,無論是緊急使用還是慢性醫療狀況。

值得注意的是,大約有 13 億支帶有胰島素藥筒的拋棄式筆在流通,為可重複使用的筆提供了大顯示器、劑量調節和輕鬆更換藥筒等便利。自動注射器作為一種實用的藥物輸送方式已廣受歡迎,特別是對於靈活性有限的患者。大多數自動注射器是拋棄式的、拋棄式的、彈簧加載的注射器。患者和照護者擴大參與選擇拋棄式自動注射器的最佳治療方案,這是該市場收入成長的關鍵驅動力。

細分市場洞察

產品洞察

根據產品,市場分為傳統注射器和安全注射器。 2022 年,安全拋棄式注射器細分市場在市場中佔據最高的收入佔有率。這主要歸因於人們對醫療保健環境中安全措施重要性的認知不斷提高,以及防止針刺傷的需求不斷成長。此外,由於注射不當導致B型肝炎、C型肝炎和愛滋病毒等血液傳染疾病的高流行,進一步刺激了對安全注射器的需求。醫療保健專業人員和組織擴大採用安全注射器作為預防措施,以降低感染風險並確保病患安全。對感染控制方案的日益重視和醫療機構嚴格法規的實施也促進了市場的成長。

應用洞察

按應用分類,市場分為免疫注射劑和治療注射劑。 2022年,免疫注射細分市場在市場中佔據了重要的收入佔有率。免疫注射的重要性在於其在預防疾病傳播和保護公眾健康方面的作用。由於疫苗接種主要是一項群眾活動,因此確保該過程的安全性和有效性變得至關重要。因此,必須盡量減少傳播血源性病原體的風險,而實現這一目標的方法之一是避免重複使用注射器和針頭,這有助於降低針刺傷的風險。

注射劑的選擇也取決於多種因素,包括安全性、成本和所注射疫苗的類型。如果所有疫苗均以預先安裝形式提供,通常建議使用預先安裝自動失效注射器。這些注射器為注射疫苗提供了便利、準確和安全,進一步增強了整體免疫過程。確保正確的注射方法,例如使用正確類型的注射器和針頭,對於維持免疫過程的完整性和確保公眾健康起著至關重要的作用。

區域洞察

2022 年,北美地區成為市場領導者,收入比重最高。這可以歸因於多種因素,包括該地區大量提供拋棄式注射器,這促進了對注射藥物的需求不斷成長。此外,該地區慢性疾病和生活方式疾病的日益普及進一步加劇了這一趨勢。此外,人們越來越重視確保患者和醫療保健提供者的安全,預計這將顯著推動市場擴張。

此外,北美先進的醫療基礎設施,加上高素質的醫療專業人員,導致醫院、專科診所和診斷設施等各種醫療機構中拋棄式注射器的使用量大幅增加。拋棄式注射器的廣泛採用凸顯了該地區為其人民提供安全且高效的醫療保健服務的承諾。

目錄

第 1 章:產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章:研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章:執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章:客戶之聲

第 5 章:全球拋棄式注射器市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 依產品(傳統注射器、安全注射器)
    • 按應用(免疫注射劑、治療注射劑)
    • 按最終使用者(醫院和診所、門診護理中心、診斷中心、其他)
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章:北美拋棄式注射器市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章:歐洲拋棄式注射器市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲:國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章:亞太地區拋棄式注射器市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章:南美洲拋棄式注射器市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲拋棄式注射器市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA:國家分析
    • 南非拋棄式注射器
    • 沙烏地阿拉伯 拋棄式注射器
    • 阿拉伯聯合大公國拋棄式注射器

第 11 章:市場動態

  • 促進要素
  • 挑戰

第 12 章:市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章:定價分析

第 14 章:全球拋棄式注射器市場:SWOT 分析

第 15 章:波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第16章:競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Gerresheimer AG
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • B. Braun SE
    • Cardinal Health, Inc.
    • Schott AG
    • Hindustan Syringes & Medical Devices Ltd
    • Nipro Corporation
    • Retractable Technologies Inc.
    • Terumo Corporation

第 17 章:策略建議

第 18 章:關於我們與免責聲明

簡介目錄
Product Code: 5165

In 2022, the Global Disposable Syringes Market reached a valuation of USD 14.20 billion, and it is poised for remarkable growth in the forecast period with a projected Compound Annual Growth Rate (CAGR) of 6.10% through 2028.

Disposable syringes consist of a plastic barrel and a needle, available in various sizes. They are employed for the safe administration of fluids, liquids, or chemicals into the human body. The key advantage of disposable syringes is their single-use nature, eliminating the need for maintenance and sterilization. This not only reduces operational costs but also minimizes the risk of post-sterilization infections. Additionally, disposable syringes are equipped with needle covers to maintain sterility and prevent accidental contact.

The disposability of these syringes facilitates efficient mass production, resulting in cost-effectiveness. Different types of disposable syringes are categorized based on factors such as size, tip design, and needle length, ensuring compatibility and suitability for various medical applications.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 14.20 Billion
Market Size 2028USD 20.32 Billion
CAGR 2023-20286.10%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Key Market Drivers

Growing Prevalence of Chronic Disorders

The surge in the cases of chronic disease and surging needle stick injuries are significantly contributing to the growth of the safety syringe market. According to a report by the Centers for Disease Control and Prevention (CDC), more than 3 million healthcare workers in the United States alone are exposed to blood and body fluid through sharp and mucocutaneous injuries, resulting in 6 million needlestick injuries annually. These needlestick injuries pose a considerable risk of infections, with transmission rates ranging from as low as 0.2% to 0.5% for HIV to as high as 3% to 10% for the Hepatitis C virus. In the case of the Hepatitis B virus, the risk of infection can escalate to a staggering 40%. The potential fatality of these infections has prompted many countries to enforce mandatory regulations for the use of safety syringes, as they have proven to be effective in reducing such infections. As a result, the demand for disposable syringes continues to grow, driven by these critical factors and the pressing need for enhanced patient safety and infection control measures.

Increase In the Geriatric Population

Another significant driver for growth is the escalating geriatric population worldwide. Type 2 Diabetes primarily affects individuals aged 45 and above, but its prevalence is gradually increasing among younger age groups. Approximately 9.6% of the global population, which stands at 7.875 billion people, comprises individuals aged 65 and above. The geriatric population is also prone to various health conditions beyond diabetes due to their advanced age. These conditions necessitate medical attention and the administration of medicinal fluids, thereby fueling the growth of the Disposable Syringes market. Technological advancements in Disposable Syringes enhance their appeal and act as catalysts for market growth. In addition to treating various diseases, the rising demand for collecting blood samples, driven by the prevalence of diverse medical conditions, further contributes to the expansion of the Global Disposable Syringes Market.

The increasing instances of botox injections also propel the demand for disposable syringes, consequently driving market growth. According to the plastic surgery statistics report from the American Society of Plastic Surgeons, approximately 7.4 million botulinum toxin (Botox) injections and 2.6 million dermal filler injections were administered in 2018.

Rise in Global Cases of Needle-stick Injuries

Needle-stick injuries, which are percutaneous piercing wounds caused by needle tips, have become a growing concern in healthcare settings. These injuries can occur during various activities such as using, handling, disassembling, or disposing of needles and syringes. Due to their high incidence rate and associated serious consequences, healthcare professionals are increasingly using syringes with safety mechanisms to mitigate the risk. This growing emphasis on safety is driving the demand for disposable syringes in the market.

According to Eucomed, an organization representing the medical technology industry in Europe, approximately 1 million needle-stick injuries occur in the region each year. This alarming statistic highlights the urgent need for preventive measures and safer medical devices.

The global disposable syringes market is also influenced by the sustained growth of the injectable drugs market and the increasing demand for point-of-care administration. As more medications are administered through injections, the demand for disposable syringes continues to rise. Technological advancements in the manufacturing of disposable syringes play a crucial role in driving the market forward. Innovations in materials, design, and safety features are enhancing the performance and usability of disposable syringes, making them more reliable and convenient for healthcare professionals. The prevalence of needle-stick injuries and the need for safer medical devices have propelled the global disposable syringes market. With the increasing focus on patient and healthcare worker safety, the demand for disposable syringes is expected to grow steadily in the coming years.

Increasing Number of Patients At Risk Of Developing Stroke

The increasing number of patients at risk of developing strokes has triggered a significant surge in the demand for disposable syringes. This growing healthcare concern is a direct consequence of several factors, including an aging population, lifestyle changes, and an overall rise in chronic health conditions such as hypertension and diabetes. As individuals age, their susceptibility to strokes and related complications rises, necessitating frequent medical interventions and injections.

Disposable syringes have become an indispensable tool in the prevention, diagnosis, and treatment of stroke-related issues. Patients suffering from strokes or at risk of developing them often require regular blood tests to monitor their cholesterol levels, coagulation factors, and glucose levels. These syringes play a pivotal role in drawing blood samples with precision, minimizing the risk of contamination, and ensuring the safety of healthcare professionals and patients alike.

The administration of medications, such as anticoagulants and thrombolytics, through disposable syringes has become commonplace in the management of stroke patients. The single-use nature of these syringes ensures accurate dosing, reduces the risk of infections, and eliminates the need for complex sterilization processes, thus improving overall patient care and safety. The increasing prevalence of stroke risk factors has intensified the demand for disposable syringes in the healthcare sector. These versatile instruments are not only instrumental in diagnosing and treating strokes but also in managing associated conditions, making them an essential component of modern medical practice in addressing the growing stroke epidemic. As healthcare providers strive to deliver the highest standard of care to an expanding patient base, the role of disposable syringes in stroke management is set to become even more crucial.

Key Market Challenges

Comparatively High One-time Cost

In underdeveloped economies and even in some regions of developing economies, there exists a significant lack of awareness regarding healthcare and safety issues. This lack of awareness poses a grave risk, as people remain oblivious to the fact that the unsafe practice of using non-retractable syringes can lead to the rapid spread of numerous contagious diseases and infections. The consequences of such situations can be fatal, further exacerbating the urgency to address this issue.

Moreover, in underdeveloped countries, a multitude of challenges such as inadequate infrastructure, limited resources, inadequate education, and insufficient technology contribute to the overall lack of awareness about safety laws and best practices in healthcare centers. These factors, combined with the comparatively higher cost of retractable safety syringes compared to conventional syringes, act as major restraints to the market's growth and the adoption of safer healthcare practices.

Addressing these multifaceted challenges requires concerted efforts from various stakeholders, including governments, healthcare organizations, and international bodies. By prioritizing education, improving infrastructure, and facilitating access to affordable safety syringes, we can work towards creating a safer healthcare environment for all individuals, regardless of their geographical location or economic status.

Stringent Government Regulations

Stringent government regulations have had a significant impact on the demand for disposable syringes, creating a challenging environment for both manufacturers and healthcare providers. While regulations are often implemented with the intention of ensuring safety and quality standards, they can sometimes unintentionally hinder the accessibility and affordability of disposable syringes. One of the keyways in which stringent regulations affect demand is through the rigorous certification and approval processes imposed on manufacturers. These processes often demand substantial time and financial resources, leading to delayed market entry and increased production costs. Consequently, these added expenses are often passed on to healthcare facilities and consumers, making disposable syringes more expensive and reducing their overall demand.

While stringent government regulations are essential for ensuring the safety and efficacy of medical devices like disposable syringes, they can inadvertently impede demand by increasing production costs, limiting innovation, and driving up prices. Balancing the need for safety with the need for affordable and accessible healthcare tools is a delicate task that policymakers must carefully consider ensuring that regulations do not hinder the vital role disposable syringes play in healthcare delivery.

Key Market Trends

Increasing Initiatives by Governments and Organizations

Governments and international health organizations are placing a growing emphasis on immunization and vaccination campaigns. This focus, especially in light of global health crises like the COVID-19 pandemic, has led to a surge in vaccine production and distribution efforts. Disposable syringes are pivotal in this context, as they ensure accurate and safe administration of vaccines. As governments commit to mass vaccination campaigns and bolster their healthcare infrastructure, the demand for disposable syringes is set to soar. Initiatives aimed at reducing the transmission of infectious diseases are driving up the demand for safe injection practices. Governments and organizations are increasingly investing in harm reduction programs, particularly in regions facing challenges related to intravenous drug use and HIV transmission. These programs often involve the distribution of sterile, single-use syringes to minimize the risk of infections. Consequently, the demand for disposable syringes is expected to increase as these harm reduction efforts expand.

Moreover, there is a growing recognition of the importance of healthcare hygiene and infection control, which further fuels the demand for disposable syringes. Hospitals, clinics, and healthcare facilities worldwide are adopting stricter protocols to minimize the risk of healthcare-associated infections. Disposable syringes, being inherently sterile and single-use, are a crucial component in achieving these objectives.

Rising Use of Autoinjector Syringes

The disposable syringe industry is undergoing gradual transformation attributed to rapid technological advancements in auto injector syringes, coupled with increasing market demand for safety syringes in surgical procedures. Currently, over 20 pharmaceutical companies have produced nearly 80 autoinjectors, with approximately 50 medications being developed as combination products for use with autoinjectors. Among these, disposable autoinjectors account for 62% of the market share, while reusable autoinjectors with various doses are being developed at an impressive pace. The device manufacturing industry has emphasized the need for user-friendly gadgets, both for emergency use and chronic medical conditions.

Notably, there are approximately 1.3 billion disposable pens with insulin cartridges in circulation, offering conveniences such as a large display, dose adjustment, and easy cartridge replacement for reusable pens. Autoinjector syringes have gained popularity as a practical means of medication delivery, particularly for patients with limited dexterity. Most autoinjectors are one-use, disposable, and spring-loaded syringes. The increasing involvement of patients and caregivers in selecting the optimal treatment option for disposable autoinjector syringes is a key driver for the revenue growth in this market.

Segmental Insights

Product Insights

On the basis of product, the market is fragmented into conventional syringe and safety syringe. The safety disposable syringe segment held the highest revenue share in the market in 2022. This is primarily attributed to the increasing awareness about the importance of safety measures in healthcare settings and the rising need to prevent needlestick injuries. Moreover, the high prevalence of blood-borne transmission diseases like hepatitis B, C, and HIV due to improper injection practices has further fueled the demand for safety syringes. Healthcare professionals and organizations are increasingly adopting safety syringes as a preventive measure to reduce the risk of infections and ensure patient safety. The growing emphasis on infection control protocols and the implementation of stringent regulations in healthcare facilities are also contributing to the market growth.

Application Insights

By application, the market is bifurcated into immunization injections and therapeutic injections. In 2022, the immunization injections segment garnered a significant revenue share in the market. The importance of immunization injections lies in their role in preventing the spread of diseases and protecting public health. As vaccination is primarily a mass activity, it becomes crucial to ensure the safety and efficacy of the process. Therefore, the risk of spreading blood-borne pathogens must be minimized, and one way to achieve this is by avoiding syringe and needle reuse, which helps reduce the risk of needle stick injuries.

The choice of injections used also depends on various factors, including the safety, cost, and type of vaccine to be administered. If all vaccines are available in the prefilled form, prefilled auto-disable syringes are often recommended. These syringes provide convenience, accuracy, and safety in administering vaccines, further enhancing the overall immunization process. Ensuring proper injection practices, such as using the right type of syringe and needle, plays a vital role in maintaining the integrity of the immunization process and safeguarding public health.

Regional Insights

In 2022, the North America region emerged as the leader in the market, generating the highest revenue share. This can be attributed to several factors, including the region's extensive availability of disposable syringes, which has facilitated the growing demand for injectable drugs. Moreover, the increasing prevalence of chronic and lifestyle diseases in the region has further contributed to this trend. Additionally, there is a growing emphasis on ensuring patient and healthcare provider safety, which is expected to significantly drive market expansion.

Furthermore, the advanced healthcare infrastructure in North America, coupled with highly qualified medical professionals, has resulted in a substantial surge in the use of disposable syringes across various healthcare settings such as hospitals, specialist clinics, and diagnostic facilities. This widespread adoption of disposable syringes underscores the region's commitment to providing safe and efficient healthcare services to its population.

Key Market Players

  • Gerresheimer AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • B. Braun SE
  • Cardinal Health, Inc.
  • Schott AG
  • Hindustan Syringes & Medical Devices Ltd
  • Nipro Corporation
  • Retractable Technologies Inc.
  • Terumo Corporation

Report Scope:

In this report, the Global Disposable Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Disposable Syringes Market, By Product:

  • Conventional Syringes
  • Safety Syringes

Disposable Syringes Market, By Application:

  • Immunization Injections
  • Therapeutic Injections

Disposable Syringes Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centres
  • Diagnostic Centres
  • Others

Disposable Syringes Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Disposable Syringes Market.

Available Customizations:

  • Global Disposable Syringes market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Disposable Syringes Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Conventional Syringes, Safety Syringes)
    • 5.2.2. By Application (Immunization Injections, Therapeutic Injections)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centres, Diagnostic Centres, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Disposable Syringes Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Disposable Syringes Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Disposable Syringes Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Disposable Syringes Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Disposable Syringes Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Disposable Syringes Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Disposable Syringes Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Disposable Syringes Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Disposable Syringes Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Disposable Syringes Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Disposable Syringes Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Disposable Syringes Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Disposable Syringes Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Disposable Syringes Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Disposable Syringes Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Disposable Syringes Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Disposable Syringes Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Disposable Syringes Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Disposable Syringes Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Disposable Syringes Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Disposable Syringes Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Disposable Syringes Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Disposable Syringes Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Disposable Syringes Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Pricing Analysis

14. Global Disposable Syringes Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Business Overview
  • 16.2. Service Offerings
  • 16.3. Recent Developments
  • 16.4. Key Personnel
  • 16.5. SWOT Analysis
    • 16.5.1. Gerresheimer AG
    • 16.5.2. Baxter International Inc.
    • 16.5.3. Becton, Dickinson and Company
    • 16.5.4. B. Braun SE
    • 16.5.5. Cardinal Health, Inc.
    • 16.5.6. Schott AG
    • 16.5.7. Hindustan Syringes & Medical Devices Ltd
    • 16.5.8. Nipro Corporation
    • 16.5.9. Retractable Technologies Inc.
    • 16.5.10. Terumo Corporation

17. Strategic Recommendations

18. About Us & Disclaimer